{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:40:47Z","timestamp":1761489647161},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T00:00:00Z","timestamp":1430179200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Muscle"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13395-015-0037-7","type":"journal-article","created":{"date-parts":[[2015,4,27]],"date-time":"2015-04-27T15:27:57Z","timestamp":1430148477000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Effect of levosimendan on the contractility of muscle fibers from nemaline myopathy patients with mutations in the nebulin gene"],"prefix":"10.1186","volume":"5","author":[{"given":"Josine M","family":"de Winter","sequence":"first","affiliation":[]},{"given":"Barbara","family":"Joureau","sequence":"additional","affiliation":[]},{"given":"Vasco","family":"Sequeira","sequence":"additional","affiliation":[]},{"given":"Nigel F","family":"Clarke","sequence":"additional","affiliation":[]},{"given":"Jolanda","family":"van der Velden","sequence":"additional","affiliation":[]},{"given":"Ger JM","family":"Stienen","sequence":"additional","affiliation":[]},{"given":"Henk","family":"Granzier","sequence":"additional","affiliation":[]},{"given":"Alan H","family":"Beggs","sequence":"additional","affiliation":[]},{"given":"Coen AC","family":"Ottenheijm","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,4,28]]},"reference":[{"issue":"June 1999","key":"37_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0960-8966(99)00129-7","volume":"10","author":"C Wallgren-Pettersson","year":"2000","unstructured":"Wallgren-Pettersson C, Laing NG. Report of the 70th ENMC International Workshop: nemaline myopathy, 11\u201313 June 1999, Naarden, The Netherlands. Neuromuscul Disord. 2000;10(June 1999):299\u2013306.","journal-title":"Neuromuscul Disord"},{"key":"37_CR2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/jmg.34.9.705","volume":"34","author":"KN North","year":"1997","unstructured":"North KN, Laing NG. Consortium I: nemaline myopathy: current concepts. The ENMC International Consortium and Nemaline Myopathy. J Med Genet. 1997;34:705\u201313.","journal-title":"J Med Genet"},{"key":"37_CR3","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1212\/01.WNL.0000046585.81304.BC","volume":"60","author":"MM Ryan","year":"2003","unstructured":"Ryan MM, Ilkovski B, Strickland CD, Schnell C, Sanoudou D, Midgett C, et al. Clinical course correlates poorly with muscle pathology in nemaline myopathy. Neurology. 2003;60:665\u201373.","journal-title":"Neurology"},{"issue":"11","key":"37_CR4","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1172\/JCI75199","volume":"124","author":"M Yuen","year":"2014","unstructured":"Yuen M, Sandaradura SA, Dowling JJ, Kostyukova AS, Moroz N, Quinlan KG, et al. Leiomodin-3 dysfunction results in thin filament disorganization and nemaline myopathy. J Clin Invest. 2014;124(11):4693\u2013708. doi:10.1172\/JCI75199. Epub 2014 Sep 24.","journal-title":"J Clin Invest"},{"key":"37_CR5","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.ajhg.2010.10.020","volume":"87","author":"N Sambuughin","year":"2010","unstructured":"Sambuughin N, Yau KS, Oliv\u00e9 M, Duff RM, Bayarsaikhan M, Lu S, et al. Dominant mutations in KBTBD13, a member of the BTB\/Kelch family, cause nemaline myopathy with cores. Am J Hum Genet. 2010;87:842\u20137.","journal-title":"Am J Hum Genet"},{"key":"37_CR6","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/mus.21788","volume":"42","author":"M Oliv\u00e9","year":"2010","unstructured":"Oliv\u00e9 M, Goldfarb LG, Lee H-S, Odgerel Z, Blokhin A, Gonzalez-Mera L, et al. Nemaline myopathy type 6: clinical and myopathological features. Muscle Nerve. 2010;42:901\u20137.","journal-title":"Muscle Nerve"},{"key":"37_CR7","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.bbrc.2012.04.074","volume":"421","author":"N Sambuughin","year":"2012","unstructured":"Sambuughin N, Swietnicki W, Techtmann S, Matrosova V, Wallace T, Goldfarb L, et al. KBTBD13 interacts with Cullin 3 to form a functional ubiquitin ligase. Biochem Biophys Res Commun. 2012;421:743\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"37_CR8","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1172\/JCI74994","volume":"124","author":"A Garg","year":"2014","unstructured":"Garg A, O\u2019Rourke J, Long C, Doering J, Ravenscroft G, Bezprozvannaya S, et al. KLHL40 deficiency destabilizes thin filament proteins and promotes nemaline myopathy. J Clin Invest. 2014;124:3529\u201339.","journal-title":"J Clin Invest"},{"key":"37_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ajhg.2013.05.004","volume":"93","author":"G Ravenscroft","year":"2013","unstructured":"Ravenscroft G, Miyatake S, Lehtokari V-L, Todd EJ, Vornanen P, Yau KS, et al. Mutations in KLHL40 are a frequent cause of severe autosomal-recessive nemaline myopathy. Am J Hum Genet. 2013;93:6\u201318.","journal-title":"Am J Hum Genet"},{"key":"37_CR10","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.ajhg.2013.10.020","volume":"93","author":"VA Gupta","year":"2013","unstructured":"Gupta VA, Ravenscroft G, Shaheen R, Todd EJ, Swanson LC, Shiina M, et al. Identification of KLHL41 mutations implicates BTB-kelch-mediated ubiquitination as an alternate pathway to myofibrillar disruption in nemaline myopathy. Am J Hum Genet. 2013;93:1108\u201317.","journal-title":"Am J Hum Genet"},{"key":"37_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2044-5040-4-11","volume":"4","author":"VA Gupta","year":"2014","unstructured":"Gupta VA, Beggs AH. Kelch proteins: emerging roles in skeletal muscle development and diseases. Skelet Muscle. 2014;4:11.","journal-title":"Skelet Muscle"},{"key":"37_CR12","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1073\/pnas.96.5.2305","volume":"96","author":"K Pelin","year":"1999","unstructured":"Pelin K, Hilpel\u00e4 P, Donner K, Sewry C, Akkari PA, Wilton SD, et al. Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy. Proc Natl Acad Sci. 1999;96:2305\u201310.","journal-title":"Proc Natl Acad Sci"},{"key":"37_CR13","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1002\/humu.22693","volume":"35","author":"V-L Lehtokari","year":"2014","unstructured":"Lehtokari V-L, Kiiski K, Sandaradura SA, Laporte J, Repo P, Frey JA, et al. Mutation update: the spectra of nebulin variants and associated myopathies. Hum Mutat. 2014;35:1418\u201326.","journal-title":"Hum Mutat"},{"key":"37_CR14","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1083\/jcb.200603119","volume":"173","author":"M-L Bang","year":"2006","unstructured":"Bang M-L, Li X, Littlefield R, Bremner S, Thor A, Knowlton KU, et al. Nebulin-deficient mice exhibit shorter thin filament lengths and reduced contractile function in skeletal muscle. J Cell Biol. 2006;173:905\u201316.","journal-title":"J Cell Biol"},{"key":"37_CR15","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1016\/j.bpj.2008.10.053","volume":"96","author":"A Castillo","year":"2009","unstructured":"Castillo A, Nowak R, Littlefield KP, Fowler VM, Littlefield RS. A nebulin ruler does not dictate thin filament lengths. Biophys J. 2009;96:1856\u201365.","journal-title":"Biophys J"},{"key":"37_CR16","first-page":"1123","volume":"296","author":"D Gokhin","year":"2009","unstructured":"Gokhin D, Bang M. Reduced thin filament length in nebulin-knockout skeletal muscle alters isometric contractile properties. Am J Resp Crit Care. 2009;296:1123\u201332.","journal-title":"Am J Resp Crit Care"},{"key":"37_CR17","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1083\/jcb.201001043","volume":"189","author":"CT Pappas","year":"2010","unstructured":"Pappas CT, Krieg PA, Gregorio CC. Nebulin regulates actin filament lengths by a stabilization mechanism. J Cell Biol. 2010;189:859\u201370.","journal-title":"J Cell Biol"},{"key":"37_CR18","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1038\/sj.emboj.7601242","volume":"25","author":"CC Witt","year":"2006","unstructured":"Witt CC, Burkart C, Labeit D, McNabb M, Wu Y, Granzier H, et al. Nebulin regulates thin filament length, contractility, and Z-disk structure in vivo. EMBO J. 2006;25:3843\u201355.","journal-title":"EMBO J"},{"key":"37_CR19","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1096\/fj.09-137729","volume":"23","author":"M-L Bang","year":"2009","unstructured":"Bang M-L, Caremani M, Brunello E, Littlefield R, Lieber RL, Chen J, et al. Nebulin plays a direct role in promoting strong actin-myosin interactions. FASEB J. 2009;23:4117\u201325.","journal-title":"FASEB J"},{"key":"37_CR20","doi-asserted-by":"publisher","first-page":"30889","DOI":"10.1074\/jbc.M109.049718","volume":"284","author":"M Chandra","year":"2009","unstructured":"Chandra M, Mamidi R, Ford S, Hidalgo C, Witt CC, Ottenheijm CA, et al. Nebulin alters cross-bridge cycling kinetics and increases thin filament activation: a novel mechanism for increasing tension and reducing tension cost. J Biol Chem. 2009;284:30889\u201396.","journal-title":"J Biol Chem"},{"issue":"Pt 6","key":"37_CR21","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1093\/brain\/awt113","volume":"136","author":"CAC Ottenheijm","year":"2013","unstructured":"Ottenheijm CAC, Buck D, de Winter JM, Ferrara C, Piroddi N, Tesi C, et al. Deleting exon 55 from the nebulin gene induces severe muscle weakness in a mouse model for nemaline myopathy. Brain. 2013;136(Pt 6):1718\u201331.","journal-title":"Brain"},{"key":"37_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/2044-5040-1-23","volume":"1","author":"MW Lawlor","year":"2011","unstructured":"Lawlor MW, Ottenheijm CA, Lehtokari V-L, Cho K, Pelin K, Wallgren-Pettersson C, et al. Novel mutations in NEB cause abnormal nebulin expression and markedly impaired muscle force generation in severe nemaline myopathy. Skelet Muscle. 2011;1:23.","journal-title":"Skelet Muscle"},{"key":"37_CR23","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jsb.2009.11.013","volume":"170","author":"CAC Ottenheijm","year":"2010","unstructured":"Ottenheijm CAC, Hooijman P, DeChene ET, Stienen GJ, Beggs AH, Granzier H. Altered myofilament function depresses force generation in patients with nebulin-based nemaline myopathy (NEM2). J Struct Biol. 2010;170:334\u201343.","journal-title":"J Struct Biol"},{"key":"37_CR24","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1093\/hmg\/ddp168","volume":"18","author":"CAC Ottenheijm","year":"2009","unstructured":"Ottenheijm CAC, Witt CC, Stienen GJ, Labeit S, Beggs AH, Granzier H. Thin filament length dysregulation contributes to muscle weakness in nemaline myopathy patients with nebulin deficiency. Hum Mol Genet. 2009;18:2359\u201369.","journal-title":"Hum Mol Genet"},{"key":"37_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nm.2618","volume":"18","author":"AJ Russell","year":"2012","unstructured":"Russell AJ, Hartman JJ, Hinken AC, Muci AR, Kawas R, Driscoll L, et al. Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases. Nat Med. 2012;18:452\u20135.","journal-title":"Nat Med"},{"key":"37_CR26","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/jmedgenet-2012-101470","volume":"50","author":"JM De Winter","year":"2013","unstructured":"De Winter JM, Buck D, Hidalgo C, Jasper JR, Malik FI, Clarke NF, et al. Troponin activator augments muscle force in nemaline myopathy patients with nebulin mutations. J Med Genet. 2013;50:383\u201392.","journal-title":"J Med Genet"},{"key":"37_CR27","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","volume":"360","author":"F Follath","year":"2002","unstructured":"Follath F, Cleland J, Just H, Papp J, Scholz H, Peuhkurinen K, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet. 2002;360:196\u2013202.","journal-title":"Lancet"},{"key":"37_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1161\/01.RES.77.1.107","volume":"77","author":"I Edes","year":"1995","unstructured":"Edes I, Kiss E, Kitada Y, Powers FM, Papp JG, Kranias EG, et al. Effects of levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart. Circ Res. 1995;77:107\u201313.","journal-title":"Circ Res"},{"key":"37_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1164\/rccm.201107-1268OC","volume":"185","author":"J Doorduin","year":"2012","unstructured":"Doorduin J, Sinderby CA, Beck J, Stegeman DF, van Hees HWH, van der Hoeven JG, et al. The calcium sensitizer levosimendan improves human diaphragm function. Am J Resp Crit Care. 2012;185:90\u20135.","journal-title":"Am J Resp Crit Care"},{"key":"37_CR30","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/j.1476-5381.2010.01048.x","volume":"162","author":"H Van Hees","year":"2011","unstructured":"Van Hees H, Andrade Acu\u00f1a G, Linkels M, Dekhuijzen P, Heunks L. Levosimendan improves calcium sensitivity of diaphragm muscle fibres from a rat model of heart failure. Br J Pharmacol. 2011;162:566\u201373.","journal-title":"Br J Pharmacol"},{"key":"37_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1164\/rccm.200805-732OC","volume":"179","author":"HWH Van Hees","year":"2009","unstructured":"Van Hees HWH, Dekhuijzen PNR, Heunks LM. Levosimendan enhances force generation of diaphragm muscle from patients with chronic obstructive pulmonary disease. Am J Resp Crit Care. 2009;179:41\u20137.","journal-title":"Am J Resp Crit Care"},{"key":"37_CR32","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.yjmcc.2009.11.019","volume":"48","author":"Y-B Sun","year":"2010","unstructured":"Sun Y-B, Irving M. The molecular basis of the steep force-calcium relation in heart muscle. J Mol Cell Cardiol. 2010;48:859\u201365.","journal-title":"J Mol Cell Cardiol"},{"key":"37_CR33","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S0008-6363(98)00019-4","volume":"38","author":"J Van der Velden","year":"1998","unstructured":"Van der Velden J, Klein L, van der Bijl M, Huybregts M, Stooker W, Witkop J, et al. Force production in mechanically isolated cardiac myocytes from human ventricular muscle tissue. Cardiovasc Res. 1998;38:414\u201323.","journal-title":"Cardiovasc Res"},{"key":"37_CR34","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/prca.200600891","volume":"1","author":"R Zaremba","year":"2007","unstructured":"Zaremba R, Merkus D, Hamdani N, Lamers JMJ, Paulus WJ, dos Remedios C, et al. Quantitative analysis of myofilament protein phosphorylation in small cardiac biopsies. Proteomics \u2013 Clin Appl. 2007;1:1285\u201390.","journal-title":"Proteomics \u2013 Clin Appl"},{"key":"37_CR35","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S1471-4914(01)02089-5","volume":"7","author":"D Sanoudou","year":"2001","unstructured":"Sanoudou D, Beggs AH. Clinical and genetic heterogeneity in nemaline myopathy\u2013a disease of skeletal muscle thin filaments. Trends Mol Med. 2001;7:362\u20138.","journal-title":"Trends Mol Med"},{"key":"37_CR36","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0022-2828(03)00178-0","volume":"35","author":"T Sorsa","year":"2003","unstructured":"Sorsa T, Pollesello P, Permi P, Drakenberg T, Kilpel\u00e4inen I. Interaction of levosimendan with cardiac troponin C in the presence of cardiac troponin I peptides. J Mol Cell Cardiol. 2003;35:1055\u201361.","journal-title":"J Mol Cell Cardiol"},{"key":"37_CR37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10974-007-9116-7","volume":"28","author":"CJ Barclay","year":"2007","unstructured":"Barclay CJ, Woledge RC, Curtin NA. Energy turnover for Ca2+ cycling in skeletal muscle. J Muscle Res Cell M. 2007;28:259\u201374.","journal-title":"J Muscle Res Cell M"},{"issue":"Pt 2","key":"37_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1469-7793.2001.0393i.x","volume":"531","author":"P Szentesi","year":"2001","unstructured":"Szentesi P, Zaremba R, van Mechelen W, Stienen GJ. ATP utilization for calcium uptake and force production in different types of human skeletal muscle fibres. J Physiol. 2001;531(Pt 2):393\u2013403.","journal-title":"J Physiol"},{"key":"37_CR39","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1023\/B:JURE.0000038365.74532.75","volume":"25","author":"Z Papp","year":"2004","unstructured":"Papp Z, Van Der Velden J, Borb\u00e9ly A, \u00c9des I, Stienen GJM. Effects of Ca 2\u2009+\u2009\u2212 sensitizers in permeabilized cardiac myocytes from donor and end-stage failing human hearts. J Muscle Res Cell Motil. 2004;25:219\u201324.","journal-title":"J Muscle Res Cell Motil"},{"key":"37_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejphar.2003.12.005","volume":"486","author":"S Szil\u00e1gyi","year":"2004","unstructured":"Szil\u00e1gyi S, Pollesello P, Levijoki J, Kaheinen P, Haikala H, \u00c9des I, et al. The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig. Eur J Pharmacol. 2004;486:67\u201374.","journal-title":"Eur J Pharmacol"},{"key":"37_CR41","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.nmd.2009.11.010","volume":"20","author":"J Ochala","year":"2010","unstructured":"Ochala J. Ca2+ sensitizers: an emerging class of agents for counterbalancing weakness in skeletal muscle diseases? Neuromusc Dis. 2010;20:98\u2013101.","journal-title":"Neuromusc Dis"}],"container-title":["Skeletal Muscle"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-015-0037-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13395-015-0037-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-015-0037-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-015-0037-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T11:16:32Z","timestamp":1630581392000},"score":1,"resource":{"primary":{"URL":"https:\/\/skeletalmusclejournal.biomedcentral.com\/articles\/10.1186\/s13395-015-0037-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,28]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["37"],"URL":"https:\/\/doi.org\/10.1186\/s13395-015-0037-7","relation":{},"ISSN":["2044-5040"],"issn-type":[{"value":"2044-5040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,28]]},"assertion":[{"value":"16 December 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"12"}}